Ranked #1
Neratinib vs Trastuzumab for Untreated Metastatic ERBB2-Positive Breast Cancer
Neratinib vs Trastuzumab for Untreated Metastatic ERBB2-Positive Breast Cancer
Interview with Ahmad Awada, MD, PhD, author of Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously U... Read more
14 Apr 2016
•
17mins
Ranked #2
Lifestyle Associations With US Cancer Incidence and Mortality
Lifestyle Associations With US Cancer Incidence and Mortality
Interview with Mingyang Song, MD, ScD, author of Preventable Incidence and Mortality of Carcinoma Associated With Lifes... Read more
19 May 2016
•
7mins
Ranked #3
Agent Orange Exposure and Monoclonal Gammopathy
Agent Orange Exposure and Monoclonal Gammopathy
Interview with Ola Landgren, MD, PhD, author of Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Signific... Read more
3 Sep 2015
•
9mins
Ranked #4
Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors
Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors
Interview with Arvind Dasari, MD, author of Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With... Read more
27 Apr 2017
•
14mins
Ranked #5
Chemoresistance After Consumption of Fish and Fish Oil
Chemoresistance After Consumption of Fish and Fish Oil
Interview with Emile E. Voest, MD, PhD, author of Increased Plasma Levels of Chemoresistance-Inducing Fatty Acid 16:4(n-... Read more
2 Apr 2015
•
8mins
Ranked #6
BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer
BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer
Interview with Ann H. Partridge, MD, MPH, author of BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer
11 Feb 2016
•
6mins
Ranked #7
Prostate-Specific Antigen Screening and Selective Treatment
Prostate-Specific Antigen Screening and Selective Treatment
Interview with Ruth Etzioni, PhD, author of Economic Analysis of Prostate-Specific Antigen Screening and Selective Trea... Read more
24 Mar 2016
•
10mins
Ranked #8
Breast Tumor Characteristics and Biennial vs Annual Mammography
Breast Tumor Characteristics and Biennial vs Annual Mammography
Interview with Diana L. Miglioretti, PhD, author of Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammo... Read more
20 Oct 2015
•
4mins
Ranked #9
Association of Colon Cancer Survival With ACS Guideline Adherence
Association of Colon Cancer Survival With ACS Guideline Adherence
Interview with Erin L. Van Blarigan, ScD, and Jeffrey A Meyerhardt, MD, MPH, authors of Association of Survival With Ad... Read more
12 Apr 2018
•
16mins
Ranked #10
Delayed Adjuvant Chemotherapy After Lung Cancer Surgery
Delayed Adjuvant Chemotherapy After Lung Cancer Surgery
Interview with Daniel Joseph. Boffa, MD, author of Association of Delayed Adjuvant Chemotherapy With Survival After Lun... Read more
5 Jan 2017
•
8mins
Ranked #11
Atezolizumab Monotherapy for Patients With Metastatic Urothelial Cancer
Atezolizumab Monotherapy for Patients With Metastatic Urothelial Cancer
Interview with Daniel P. Petrylak, MD, PhD, author of Atezolizumab (MPDL3280A) Monotherapy for Patients With Metastatic... Read more
8 Feb 2018
•
8mins
Ranked #12
Critical Lessons From High-Value Oncology Practices
Critical Lessons From High-Value Oncology Practices
Interview with Douglas W. Blayney, MD, author of Critical Lessons From High-Value Oncology Practices
16 Nov 2017
•
11mins
Ranked #13
Trends in Reoperation After Initial Lumpectomy for Breast Cancer
Trends in Reoperation After Initial Lumpectomy for Breast Cancer
Interview with Monica Morrow, MD, author of Trends in Reoperation After Initial Lumpectomy for Breast Cancer: Addressin... Read more
5 Jun 2017
•
12mins
Ranked #14
Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade
Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade
Interview with Aaron Goodman, MD, author of Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpo... Read more
14 Jun 2018
•
9mins
Ranked #15
Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Trials
Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Trials
Interview with Ethan M. Basch, MD, MSc, author of Feasibility Assessment of Patient Reporting of Symptomatic Adverse Ev... Read more
16 Feb 2017
•
6mins
Ranked #16
Birth Outcomes Among Adolescent and Young Adult Cancer Survivors
Birth Outcomes Among Adolescent and Young Adult Cancer Survivors
Interview with Hazel B. Nichols, PhD, author of Birth Outcomes Among Adolescent and Young Adult Cancer Survivors
23 Mar 2017
•
8mins
Ranked #17
Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non–Small Cell Lung Cancer
Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non–Small Cell Lung Cancer
Interview with David A. Palma, MD, PhD, author of Measuring the Integration of Stereotactic Ablative Radiotherapy Plus ... Read more
21 Feb 2019
•
14mins
Ranked #18
Outcomes of Multiple-Gene Sequencing After Diagnosis of Breast Cancer
Outcomes of Multiple-Gene Sequencing After Diagnosis of Breast Cancer
Interview with Allison W. Kurian, M.D., M.Sc., author of Uptake, Results, and Outcomes of Germline Multiple-Gene Sequen... Read more
10 May 2018
•
7mins
Ranked #19
Surgery vs Radiotherapy in the Management of Gleason Score 9-10 Prostate Cancer and the Risk of Mortality
Surgery vs Radiotherapy in the Management of Gleason Score 9-10 Prostate Cancer and the Risk of Mortality
Interview with Anthony D'Amico, MD, PhD, author of Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-... Read more
15 Nov 2018
•
19mins
Ranked #20
The Global Burden of Cancer 2013
The Global Burden of Cancer 2013
Interview with Christopher Murray, DPhil, MD and Christina Fitzmaurice, MD, MPH, authors of The Global Burden of Cancer ... Read more
28 May 2015
•
6mins